View in EDS

Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 phox -deficient chronic granulomatous disease.

Saved in:
Bibliographic Details
Title: Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 phox -deficient chronic granulomatous disease.
Authors: Siow KM; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Güngör M; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Wrona D; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Raimondi F; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Pastukhov O; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Tsapogas P; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Menzi T; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Schmitz M; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland., Kulcsár PI; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland., Schwank G; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland., Schulz A; Department of Pediatrics, University Medical Center Ulm, 89075 Ulm, Germany., Jinek M; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland., Modlich U; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland., Siler U; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.; School of Life Sciences, Institute for Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, 4132 Muttenz, Switzerland., Reichenbach J; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.; Department of Somatic Gene Therapy, University Children's Hospital Zurich, 8032 Zurich, Switzerland.; Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, 8057 Zurich, Switzerland.
Source: Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 May 24; Vol. 35 (3), pp. 102229. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38952440
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 <superscript>phox</superscript> -deficient chronic granulomatous disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Siow+KM%22">Siow KM</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Güngör+M%22">Güngör M</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wrona+D%22">Wrona D</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Raimondi+F%22">Raimondi F</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pastukhov+O%22">Pastukhov O</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tsapogas+P%22">Tsapogas P</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Menzi+T%22">Menzi T</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schmitz+M%22">Schmitz M</searchLink>; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kulcsár+PI%22">Kulcsár PI</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schwank+G%22">Schwank G</searchLink>; Institute of Pharmacology and Toxicology, University of Zurich, 8057 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schulz+A%22">Schulz A</searchLink>; Department of Pediatrics, University Medical Center Ulm, 89075 Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Jinek+M%22">Jinek M</searchLink>; Department of Biochemistry, University of Zurich, 8057 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Modlich+U%22">Modlich U</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Siler+U%22">Siler U</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.; School of Life Sciences, Institute for Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, 4132 Muttenz, Switzerland.<br /><searchLink fieldCode="AU" term="%22Reichenbach+J%22">Reichenbach J</searchLink>; Division of Gene and Cell Therapy, Institute for Regenerative Medicine, University of Zurich, Schlieren, 8952 Zurich, Switzerland.; Department of Somatic Gene Therapy, University Children's Hospital Zurich, 8032 Zurich, Switzerland.; Center for Applied Biotechnology and Molecular Medicine (CABMM), University of Zurich, 8057 Zurich, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2024 May 24; Vol. 35 (3), pp. 102229. <i>Date of Electronic Publication: </i>2024 May 24 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38952440
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omtn.2024.102229
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102229
    Titles:
      – TitleFull: Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 phox -deficient chronic granulomatous disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Siow KM
      – PersonEntity:
          Name:
            NameFull: Güngör M
      – PersonEntity:
          Name:
            NameFull: Wrona D
      – PersonEntity:
          Name:
            NameFull: Raimondi F
      – PersonEntity:
          Name:
            NameFull: Pastukhov O
      – PersonEntity:
          Name:
            NameFull: Tsapogas P
      – PersonEntity:
          Name:
            NameFull: Menzi T
      – PersonEntity:
          Name:
            NameFull: Schmitz M
      – PersonEntity:
          Name:
            NameFull: Kulcsár PI
      – PersonEntity:
          Name:
            NameFull: Schwank G
      – PersonEntity:
          Name:
            NameFull: Schulz A
      – PersonEntity:
          Name:
            NameFull: Jinek M
      – PersonEntity:
          Name:
            NameFull: Modlich U
      – PersonEntity:
          Name:
            NameFull: Siler U
      – PersonEntity:
          Name:
            NameFull: Reichenbach J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 05
              Text: 2024 May 24
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2162-2531
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular therapy. Nucleic acids
              Type: main
ResultId 1